Dr. Judith Joseph

Psychiatry
Carepoint Health Hoboken University Medical Center
308 Willow Ave, 
Hoboken, NJ 
Carepoint Health Hoboken University Medical Center
308 Willow Ave, 
Hoboken, NJ 

Overview

Judith Joseph is a Psychiatrist practicing medicine in Hoboken, New Jersey.

Her clinical expertise encompasses Alzheimer's Disease and Dementia.

She is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 8 clinical trials.

Specialties

Psychiatry

Licenses

Psychiatry & Neurology in NY

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Carepoint Health Hoboken University Medical Center
308 Willow Ave, Hoboken, NJ 07030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
Enrollment Status: Completed
Publish Date: May 29, 2025
Intervention Type: Drug
Study Drug: BTRX-335140
Study Phase: Phase 2
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2/Phase 3
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Drug
Study Drug: BPN14770
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 19, 2024
Intervention Type: Drug
Study Drug: T3D-959
Study Phase: Phase 2
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled Proof-of-Concept Study of a Selective p38 MAP Kinase Alpha Inhibitor, Neflamapimod, Administered for 24 Weeks in Subjects With Mild Alzheimer's Disease
A Double-Blind, Placebo-Controlled Proof-of-Concept Study of a Selective p38 MAP Kinase Alpha Inhibitor, Neflamapimod, Administered for 24 Weeks in Subjects With Mild Alzheimer's Disease
Enrollment Status: Completed
Publish Date: October 27, 2021
Intervention Type: Drug, Other
Study Phase: Phase 2
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
Enrollment Status: Terminated
Publish Date: September 05, 2021
Intervention Type: Combination product
Study Drug: ABILIFY MYCITE
Study Phase: Phase 3
View 7 Less Clinical Trials

1 Total Publications

Understanding High-Functioning Depression in Adults.
Understanding High-Functioning Depression in Adults.
Journal: Cureus
Published: February 12, 2025
Similar Doctors
Expertise in
1
conditions
Dr. Lenard Adler
Psychiatry
Expertise in
1
conditions
Dr. Lenard Adler
Psychiatry

NYU Langone Psychiatry Associates

1 Park Ave Fl 8, 
New York, NY 
 (15.5 miles away)
212-263-3580
Languages Spoken:
English
See accepted insurances

Lenard Adler is a Psychiatrist practicing medicine in New York, New York. Dr. Adler is highly rated in 1 condition, according to our data. His clinical expertise encompasses Attention Deficit Hyperactivity Disorder (ADHD).

Expertise in
1
conditions
Dr. John Rotrosen
Psychiatry
Expertise in
1
conditions
Dr. John Rotrosen
Psychiatry

Veterans Affairs New York Harbor Healthcare System-Manhattan Campus

423 E 23rd St, 
New York, NY 
 (16.0 miles away)
212-951-3294
Languages Spoken:
English

John Rotrosen is a Psychiatrist practicing medicine in New York, New York. Dr. Rotrosen is highly rated in 1 condition, according to our data. His clinical expertise encompasses Opioid Use Disorder.

Expertise in
2
conditions
Dr. Joanna Steinglass
Psychiatry
Expertise in
2
conditions
Dr. Joanna Steinglass
Psychiatry

Office

262 Central Park W Ste 1A, 
New York, NY 
 (13.1 miles away)
212-579-1882
Languages Spoken:
English
See accepted insurances

Joanna Steinglass is a Psychiatrist practicing medicine in New York, New York. Dr. Steinglass is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Anorexia, Bulimia, and Obsessive-Compulsive Disorder (OCD).

Frequently Asked Questions about Dr. Judith Joseph

How do I make an appointment with Dr. Judith Joseph?

You can book an appointment with Dr. Judith Joseph by calling their office at 201-418-1285. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Judith Joseph a top-rated expert for Alzheimer's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Judith Joseph is classified as an Experienced expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Judith Joseph specialize in?

While Dr. Judith Joseph is a Psychiatry, they have specific expertise in Alzheimer's Disease, Dementia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Judith Joseph participate in research or clinical trials?

Yes. Dr. Judith Joseph has published 1 articles and abstracts on conditions like Alzheimer's Disease. You can view a list of Dr. Judith Joseph's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Judith Joseph accept my insurance?

Dr. Judith Joseph accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 201-418-1285 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Joseph's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile